Growth Metrics

Neurocrine Biosciences (NBIX) Inventory: 2017-2021

Historic Inventory for Neurocrine Biosciences (NBIX) over the last 4 years, with Sep 2021 value amounting to $25.5 million.

  • Neurocrine Biosciences' Inventory rose 23.79% to $25.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $25.5 million, marking a year-over-year increase of 23.79%. This contributed to the annual value of $28.0 million for FY2020, which is 61.85% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Inventory stood at $25.5 million for Q3 2021, which was down 9.89% from $28.3 million recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Inventory peaked at $30.1 million during Q1 2021, and registered a low of $128,000 during Q2 2017.
  • For the 3-year period, Neurocrine Biosciences' Inventory averaged around $20.8 million, with its median value being $21.2 million (2020).
  • Data for Neurocrine Biosciences' Inventory shows a peak YoY spiked of 2,401.65% (in 2018) over the last 5 years.
  • Over the past 5 years, Neurocrine Biosciences' Inventory (Quarterly) stood at $1.0 million in 2017, then surged by 960.94% to $10.9 million in 2018, then soared by 59.24% to $17.3 million in 2019, then skyrocketed by 61.85% to $28.0 million in 2020, then rose by 23.79% to $25.5 million in 2021.
  • Its Inventory stands at $25.5 million for Q3 2021, versus $28.3 million for Q2 2021 and $30.1 million for Q1 2021.